Company Filing History:
Years Active: 2007
Title: The Innovator Behind Oncosuppressive Gene: Maurizio D'Incalci
Introduction: Maurizio D'Incalci is a notable inventor based in Bresso, Italy, recognized for his contributions to the field of genetics and cancer research. With a focus on the apoptotic process, his work has significant implications for understanding cancer development and treatment.
Latest Patents: D'Incalci holds a patent for the isolation and characterization of an oncosuppressive gene, which is intricately involved in the apoptotic process. This gene is regulated by p53 and p73, with the patent detailing the polypeptide encoded by this gene, the sequences involved in its regulation, and genetic constructs derived thereof. This innovative approach offers new possibilities for targeting cancer at the genetic level.
Career Highlights: Maurizio D'Incalci is currently contributing his expertise at Novuspharma S.p.a., where he engages in groundbreaking research that fosters advancements in the biotechnology sector. His deep understanding of molecular biology and genetics has made him an invaluable asset in the fight against cancer.
Collaborations: D'Incalci collaborates closely with his coworker, Massimo Broggini, pooling their knowledge and skills to further the research in oncosuppressive mechanisms and therapies. Their combined efforts are aimed at propelling innovations that could lead to more effective cancer treatments.
Conclusion: Maurizio D'Incalci's innovative work in the isolation and characterization of oncosuppressive genes marks him as a pivotal figure in cancer research. His patent not only reflects his dedication to scientific advancement but also contributes significantly to the ongoing pursuit of understanding and combating cancer.